medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2019, Número 4

<< Anterior Siguiente >>

Rev Mex Urol 2019; 79 (4)


Efecto de la electroestimulación del nervio tibial en la musculatura del piso pélvico de pacientes con síndrome de vejiga hiperactiva

Pérez-Martínez C, Palacios-Galicia JL, Vargas-Díaz IB, Cruz-Gómez Y, García-Sánchez D

Idioma: Español
Referencias bibliográficas: 32
Paginas: 1-11
Archivo PDF: 315.27 Kb.


RESUMEN

Antecedentes y Objetivos: El Síndrome de Vejiga Hiperactiva (svh) presenta alteraciones motoras como hipertonía de la musculatura del piso pélvico (MPP). El objeto del estudio es demostrar las características de la electromiografía de superficie (EMGS) del MPP en el SVH tratados con electro-estimulación percutánea del nervio tibial (PTNS).
Material y Método: Estudio prospectivo, observacional, controlado. Se realizó EMGS de MPP a 17 voluntarios con SVH rebelde a tratamiento, antes, durante la PTNS y 72 horas después. Se asignaron 2 grupos: Catorce voluntarios del grupo ptns, y 3 voluntarios del grupo placebo. Se incluyeron pacientes con evolución mínima de 6 meses, frecuencia urinaria de 8 o más, sin toma de medicamentos. Se excluyeron pacientes con urocultivo/espermocultivo positivos, litiasis, biopsia y/o cirugía de órganos pélvicos ó cáncer pélvico, y lesiones del SNC. Las variables se analizaron mediante Anova y Tukey pos hoc test, 95% ic, usando el software SPSS 10.1.
Resultados: Media de edad 34.23±12.90 años, media del tiempo de evolución 19.58±12.08 meses, sin diferencia estadística en entre grupos. La diferencia de las medias en el promedio de EMG (AVGEMG) del grupo PTNS pre vs trans de 0.125 µV y de pre vs 72 horas de 0.171 µV fueron significativas (p‹0.05), mientras que en el grupo placebo la diferencia de las medias AVGEMG de 0.013 µV y 0.006 µV sin diferencia estadística (p›0.05).
Conclusiones: El cambio inmediato sobre la MPP que permanece hasta 72 horas después de la TPNS, es un posible mecanismo de acción de neuroplasticidad de la neuromodulación del nervio tibial.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. [accessed 11 Jul 2019] Available from: https://www.goldjournal. net/article/S0090-4295(02)02243-4/abstract

  2. de Urodinámica GE, Sinug D. Consenso sobre terminología y conceptos de la función del tracto urinario inferior. Actas Urol Esp. 2005;29(1):16–30. [accessed 3 Sep 2019] Available from: http://www.elsevier.es/esrevista- actas-urologicas-espanolas-292-articuloconsenso- sobre-terminologia-conceptosfuncion- S0210480605731946

  3. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/ International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5– 26. doi: https://doi.org/10.1007/s00192-009- 0976-9

  4. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen C-I, Milsom I. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm. 2014;20(2):130–40. doi: https://doi. org/10.18553/jmcp.2014.20.2.130

  5. Prieto L, Castro D, Esteban M, Salinas J, Jimenez M, Mora A. [Descriptive epidemiological study of the diagnosis of detrusor overactivity in urodynamic units in Spain]. Actas Urol Esp. 2012;36(1):21–8. doi: https://doi. org/10.1016/j.acuro.2011.06.015

  6. García-Sánchez D, Gutiérrez-González A, Pérez-Ortega R, Gastelum-Félix LA, Reyes-Gutiérrez MÁ. Frecuencia de la vejiga hiperactiva en médicos generales. Rev Mex Urol. 2014;74(2):84–7. [accessed 3 Sep 2019] Available from: http://www.elsevier. es/es-revista-revista-mexicana-urologia-302- articulo-frecuencia-vejiga-hiperactiva-medicosgenerales- S2007408515300173

  7. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7. doi: https://doi.org/10.1002/nau.22295

  8. Apostolidis A, Averbeck MA, Sahai A, Rahnama’i MS, Anding R, Robinson D, et al. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015). Neurourol Urodyn. 2017;36(4):882–93. doi: https://doi.org/10.1002/nau.23170

  9. Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80. doi: https://doi. org/10.1016/j.juro.2015.01.087

  10. Wibisono E, Rahardjo HE. Effectiveness of Short Term Percutaneous Tibial Nerve Stimulation for Non-neurogenic Overactive Bladder Syndrome in Adults: A Meta-analysis. Acta Med Indones. 2015;47(3):188–200.

  11. Chang CJ, Huang ST, Hsu K, Lin A, Stoller ML, Lue TF. Electroacupuncture decreases c-fos expression in the spinal cord induced by noxious stimulation of the rat bladder. J Urol. 1998;160(6 Pt 1):2274–9. doi: https://doi. org/10.1097/00005392-199812010-00099

  12. Griffiths D, Tadic SD. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol Urodyn. 2008;27(6):466–74. doi: https://doi. org/10.1002/nau.20549

  13. Mally AD, Matsuta Y, Zhang F, Shen B, Wang J, Roppolo JR, et al. Role of opioid and metabotropic glutamate 5 receptors in pudendal inhibition of bladder overactivity in cats. J Urol. 2013;189(4):1574–9. doi: https://doi. org/10.1016/j.juro.2012.09.095

  14. Engineer CT, Hays SA, Kilgard MP. Vagus nerve stimulation as a potential adjuvant to behavioral therapy for autism and other neurodevelopmental disorders. J Neurodev Disord. 2017;9:20. doi: https://doi.org/10.1186/ s11689-017-9203-z

  15. Amend B, Matzel KE, Abrams P, de Groat WC, Sievert K-D. How does neuromodulation work. Neurourol Urodyn. 2011;30(5):762–5. doi: https://doi.org/10.1002/nau.21096

  16. Braun PM, Baezner H, Seif C, Boehler G, Bross S, Eschenfelder CC, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol. 2002;41(5):562– 6; discussion 566-567. doi: https://doi. org/10.1016/s0302-2838(02)00029-5

  17. Gad PN, Roy RR, Zhong H, Gerasimenko YP, Taccola G, Edgerton VR. Neuromodulation of the neural circuits controlling the lower urinary tract. Exp Neurol. 2016;285(Pt B):182–9. doi: https://doi.org/10.1016/j. expneurol.2016.06.034

  18. Coyne KS, Thompson CL, Lai J-S, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34(3):255– 63. doi: https://doi.org/10.1002/nau.22559

  19. Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006;49(6):1079–86. doi: https://doi. org/10.1016/j.eururo.2006.01.007

  20. Hetrick DC, Glazer H, Liu Y-W, Turner JA, Frest M, Berger RE. Pelvic floor electromyography in men with chronic pelvic pain syndrome: a case-control study. Neurourol Urodyn. 2006;25(1):46–9. doi: https://doi.org/10.1002/ nau.20162

  21. Smith MD, Coppieters MW, Hodges PW. Postural response of the pelvic floor and abdominal muscles in women with and without incontinence. Neurourol Urodyn. 2007;26(3):377–85. doi: https://doi. org/10.1002/nau.20336

  22. van Balken MR, Vergunst H, Bemelmans BLH. The use of electrical devices for the treatment of bladder dysfunction: a review of methods. J Urol. 2004;172(3):846–51. doi: https://doi. org/10.1097/01.ju.0000134418.21959.98

  23. Peters K, Carrico D, Burks F. Validation of a sham for percutaneous tibial nerve stimulation (PTNS). Neurourol Urodyn. 2009;28(1):58–61. doi: https://doi.org/10.1002/nau.20585

  24. Martinez CP, Diaz IBV. Skin surface electromiography in chronic prostatitis Type III/Chronic Pelvic Pain Syndrome. A Case Control Study. The Journal of Urology. 2009; [accessed 3 Sep 2019] Available from: https:// www.auajournals.org/doi/abs/10.1016/S0022- 5347%2809%2960345-1

  25. Smith MD, Coppieters MW, Hodges PW. Is balance different in women with and without stress urinary incontinence? Neurourol Urodyn. 2008;27(1):71–8. doi: https://doi.org/10.1002/ nau.20476

  26. Kabay SC, Kabay S, Yucel M, Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Neurourol Urodyn. 2009;28(1):62–7. doi: https://doi.org/10.1002/nau.20593

  27. De Groat WC, Ryall RW. Recurrent inhibition in sacral parasympathetic pathways to the bladder. J Physiol (Lond). 1968;196(3):579–91. doi: https://doi.org/10.1113/jphysiol.1968. sp008524

  28. Tai C, Chen M, Shen B, Wang J, Roppolo JR, de Groat WC. Irritation Induced Bladder Overactivity Is Suppressed by Tibial Nerve Stimulation in Cats. J Urol. 2011;186(1):326– 30. [accessed 3 Sep 2019] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3138204/

  29. Matsuta Y, Mally AD, Zhang F, Shen B, Wang J, Roppolo JR, et al. Contribution of opioid and metabotropic glutamate receptor mechanisms to inhibition of bladder overactivity by tibial nerve stimulation. Am J Physiol Regul Integr Comp Physiol. 2013;305(2):R126-133. doi: https://doi.org/10.1152/ajpregu.00572.2012

  30. Thor KB, de Groat WC. Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles. Am J Physiol Regul Integr Comp Physiol. 2010;299(2):R416-438. doi: https://doi.org/10.1152/ajpregu.00111.2010

  31. Abejón D, Reig E. Is pulsed radiofrequency a neuromodulation technique? Neuromodulation. 2003;6(1):1–3. doi: https://doi.org/10.1046/ j.1525-1403.2003.03009.x

  32. Finazzi-Agrò E, Rocchi C, Pachatz C, Petta F, Spera E, Mori F, et al. Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn. 2009;28(4):320–4. doi: https://doi. org/10.1002/nau.20651




2020     |     www.medigraphic.com